Cure8 research brief
Why This Matters
CDI is a common and serious complication in people hospitalized with IBD. Understanding whether CDI independently increases the risk of death, ICU care, or surgery — or mainly drives longer stays and higher costs — helps patients, clinicians, and hospitals plan care and resources.
Who Should Pay Attention
Hospitalized adult IBD patients and their caregivers; inpatient gastroenterology and infectious disease clinicians; health services researchers and hospital administrators.
Study Snapshot
What To Know
This study used the National Inpatient Sample (2016–2021) to compare hospitalized adults with IBD who did and did not have a coded diagnosis of CDI. The primary outcomes included in-hospital mortality, colectomy, ICU admission, and measures of healthcare utilization (length of stay and charges).
The key takeaway is that while raw (unadjusted) outcomes were worse for IBD patients with CDI, statistical adjustment for confounders removed an independent association between CDI and death, ICU admission, or need for colectomy. However, CDI remained linked to longer hospital stays and higher costs.
Keep In Mind
The source is an abstract-level preprint using the National Inpatient Sample (2016–2021). Results are observational and based on administrative ICD-10 coding, which can affect diagnosis accuracy and risk adjustment. The abstract indicates adjusted analyses; read the full preprint for methods, covariates, and limitations.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.